Longevity & Aging
Immutrin Raises $87M to Develop Heart Amyloid Clearing Therapy
UK biotech secures major funding for antibody therapy targeting protein buildup that damages hearts in amyloidosis patients.
Press Release
Mar 30, 2026 0
Advanced Therapies
1741 articles in this topic
Regenerative Medicine
PRP-Based Scaffolds Show Promise for Accelerating Chronic Wound Healing
New regenerative therapy combines platelet-rich plasma with biomaterial scaffolds to enhance wound repair through multiple healing pathways.
Research Paper
Mar 30, 2026 4
Regenerative Medicine
Extracellular Vesicles Show Promise as Revolutionary Hair Loss Treatment
New review reveals how tiny cellular particles could transform alopecia treatment with better safety and effectiveness than current options.
Research Paper
Mar 30, 2026 0
Longevity & Aging
First Senotherapeutic Drug Shows Promise in Phase 1 Trial for Targeting Aging Cells
Rubedo's RLS-1496 demonstrates early clinical signals in removing senescent cells through GPX4 modulation in human skin tissue.
Press Release
Mar 30, 2026 1
Regenerative Medicine
Urine-Derived Stem Cells Show Promise for Reversing Aging Through Telomerase Activity
New research reveals stem cells from urine contain telomerase activity that could combat aging by maintaining telomeres and rejuvenating tissues.
Research Paper
Mar 30, 2026 0
Longevity & Aging
Rubedo's RLS-1496 Shows Promise in Phase 1 Trial for Psoriasis Treatment
Topical therapy RLS-1496 met primary endpoints in Phase 1 trial with no serious adverse events in psoriasis patients.
Press Release
Mar 30, 2026 0
Regenerative Medicine
Natural Compounds and Stem Cells Show Promise for Reversing Cellular Aging
New review reveals how plant-based compounds and stem cell therapies could eliminate aging cells and restore youthful function.
Research Paper
Mar 30, 2026 1
Longevity & Aging
New kidney drug shows 35% improvement in Phase 2 trial for genetic disease
Maze Therapeutics' MZE829 reduced kidney damage markers by over 35% in patients with APOL1-mediated kidney disease in Phase 2 trials.
Press Release
Mar 30, 2026 0
Longevity & Aging
DNA Methylation Clocks Predict Lung Cancer Risk Better Than Standard Models
Epigenetic aging markers outperformed traditional risk assessment tools in predicting lung cancer among smokers.
Research Paper
Mar 30, 2026 0
Longevity & Aging
Epigenetic Aging Clocks Fail to Predict Parkinson's Disease Risk in 19-Year Study
Harvard researchers found that biological aging markers cannot reliably predict who will develop Parkinson's disease or when.
Research Paper
Mar 30, 2026 0
Longevity & Aging
DNA Methylation Clocks Reveal How Fast You're Really Aging
Major review of 435 studies shows DNA methylation patterns can accurately measure biological age beyond chronological years.
Research Paper
Mar 30, 2026 0
Longevity & Aging
Just Minutes of Vigorous Activity Daily Cuts Disease Risk by Up to 63 Percent
New study of 96,000 people shows brief bursts of intense activity dramatically reduce risks of heart disease, dementia, and diabetes.
Press Release
Mar 30, 2026 7